Base Pharmacy (india) Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Base Pharmacy (india) Pharmaceutical Export Portfolio Dataset — 3 Products, $4.9M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Base Pharmacy (india) — Pharmaceutical Exporter Profile (2026) | 3 Products, $4.9M Trade | TransData Nexus

Base Pharmacy (india)

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $4.9M Total Trade · DGFT Verified

Base Pharmacy (india) is an Indian pharmaceutical exporter with a total trade value of $4.9M across 3 products in 2 therapeutic categories. Based on 98 verified export shipments from Indian Customs (DGFT) records, Base Pharmacy (india) is the #1 Indian exporter in 2 products including Ibuprofen Paracetamol, Paracetamol Caffeine. Top exports include Caffeine ($3.8M), Ibuprofen Paracetamol ($600.0K), Paracetamol Caffeine ($500.0K).

Base Pharmacy (india) — Export Portfolio & Destination Treemap

Base Pharmacy (india) pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Base Pharmacy (india)? — Company Overview & Market Position

Base Pharmacy (India) Private Limited, established on July 14, 2021, is a private limited company headquartered in Vadodara, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U51909GJ2021PTC124110. Its authorized and paid-up capital stands at ₹100,000 each. The registered office is located at 403, Pavanveer Plaza, Opp. Indian Oil Petrol Pump, Sama Savli Road, Vadodara, Gujarat, 390008.

The company specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. Its product portfolio spans various therapeutic categories such as antibiotics, anti-infectives, anti-inflammatory, anti-arthritic, cardiovascular, anti-diabetics, anti-malarial, cough and cold remedies, multi-vitamins and minerals, anxiolytics, antihistamines, analgesics, antacids, anti-flatulent, erectile dysfunction, veterinary drugs, herbal medicine, and herbal cosmetics.

As of the latest available data, the company has a workforce of zero employees, indicating that it may operate with a lean structure or rely on contract manufacturing partners.

What Does Base Pharmacy (india) Export? — Product Portfolio Analysis

Top Products by Export Value

1Caffeine$3.8M

Product Portfolio — Top 3 by Export Value

Base Pharmacy (india) exports 3 pharmaceutical products across 2 therapeutic categories. Market leader (#1 exporter) in 2 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Caffeine	Respiratory & OTC	$3.8M	76	2.0%	7
2	Ibuprofen Paracetamol	Combination Drugs	$600.0K	12	31.2%	1
3	Paracetamol Caffeine	Combination Drugs	$500.0K	10	36.1%	1

Base Pharmacy (india) exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $4.9M. The company is the #1 Indian exporter in 2 products: Ibuprofen Paracetamol, Paracetamol Caffeine. The top category is Respiratory & OTC (77.6% of portfolio), followed by Combination Drugs (22.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Base Pharmacy (india) — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

As of the latest available data, the company has a workforce of zero employees, indicating that it may operate with a lean structure or rely on contract manufacturing partners.

2Manufacturing Facilities

Base Pharmacy (India) Private Limited operates a manufacturing facility located near Vadodara, Gujarat. The facility is WHO-GMP certified, adhering to international standards for Good Manufacturing Practices. It is equipped to produce a wide range of pharmaceutical products, including tablets, capsules, syrups, and injections. The plant's capacity and specific specializations are not publicly disclosed.

3Key Leadership

The company's leadership comprises two directors:

Nimeshbhai Ranchhodbhai Patel: Appointed as a director on July 14, 2021.

Hetal Nimesh Patel: Also appointed as a director on July 14, 2021.

Detailed information regarding other key executives, such as the CEO, CFO, and their specific roles, is not publicly available.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Base Pharmacy (india) Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Base Pharmacy (India) Private Limited's export activities are primarily focused on emerging markets in Africa and Southeast Asia. The company has a significant presence in countries such as Ghana, Nigeria, Kenya, Liberia, Cambodia, Myanmar, Laos, and the Philippines. While the company emphasizes its commitment to quality and regulatory compliance, specific details regarding regulatory filings, approvals, and market access status in the United States, European Union, United Kingdom, Australia, and Japan are not publicly disclosed.

2Emerging Markets

The company's strategic focus on emerging markets in Africa and Southeast Asia aligns with its mission to provide high-quality, affordable medicines to regions with growing healthcare needs. By catering to these markets, Base Pharmacy (India) Private Limited aims to expand its global footprint and contribute to improving healthcare access in these regions. The company's adherence to WHO-GMP standards and its emphasis on quality assurance support its efforts to meet international regulatory requirements and gain market acceptance in these emerging economies.

3Geographic Strategy

Base Pharmacy (india) — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Base Pharmacy (India) Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's export activities are primarily directed towards emerging markets in Africa and Southeast Asia, and it is unclear whether it has pursued approvals for the U.S. market.

2WHO & EU GMP

The company's manufacturing facility is WHO-GMP certified, indicating compliance with international standards for Good Manufacturing Practices. This certification underscores the company's commitment to producing high-quality pharmaceutical products. However, there is no publicly available information regarding EU GMP certification or EDQM status.

3CDSCO & Indian Regulatory

Base Pharmacy (India) Private Limited holds manufacturing licenses from the Central Drugs Standard Control Organization (CDSCO), the national regulatory authority in India. The company's registered office is located in Vadodara, Gujarat, and it is registered under the Corporate Identification Number (CIN) U51909GJ2021PTC124110. Specific details regarding state drug controller approvals and export No Objection Certificates (NOCs) are not publicly disclosed.

Base Pharmacy (india) — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Base Pharmacy (India) Private Limited operates in a competitive landscape with numerous pharmaceutical manufacturers catering to both domestic and international markets. While specific competitors in overlapping categories are not publicly identified, the company's emphasis on quality, adherence to WHO-GMP standards, and focus on emerging markets position it to compete effectively. The company's product portfolio spans a wide range of therapeutic classes, allowing it to address diverse market needs and differentiate itself from competitors.

2Key Differentiators

Base Pharmacy (India) Private Limited's key differentiators include its commitment to quality, as evidenced by its WHO-GMP certification, and its strategic focus on emerging markets in Africa and Southeast Asia. The company's ability to offer a diverse product portfolio across various therapeutic classes enables it to meet a broad spectrum of healthcare needs. Additionally, the company's emphasis on providing customized solutions and understanding market requirements allows it to build strong relationships with clients and consumers.

3Strategic Position

Buyer Due Diligence Brief — Evaluating Base Pharmacy (india) as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Base Pharmacy (India) Private Limited demonstrates a commitment to quality and regulatory compliance, as evidenced by its WHO-GMP certification. The company's focus on emerging markets and its diverse product portfolio indicate a proactive approach to market expansion and customer engagement. However, the lack of publicly available information regarding its workforce and specific manufacturing capabilities suggests that potential partners should conduct thorough due diligence to assess the company's operational capacity and reliability.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Confirm the validity of the WHO-GMP certification to ensure adherence to international manufacturing standards.

EU GMP Certification: If applicable, verify EU GMP certification to assess compliance with European manufacturing standards.

Frequently Asked Questions — Base Pharmacy (india)

How many pharmaceutical products does Base Pharmacy (india) export from India?

Base Pharmacy (india) exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Caffeine ($3.8M), Ibuprofen Paracetamol ($600.0K), Paracetamol Caffeine ($500.0K). Total export value is $4.9M.

What is Base Pharmacy (india)'s total pharmaceutical export value?

Base Pharmacy (india)'s total pharmaceutical export value is $4.9M, based on 98 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Base Pharmacy (india) the #1 Indian exporter?

Base Pharmacy (india) is the #1 Indian exporter in 2 products: Ibuprofen Paracetamol (31.2% market share), Paracetamol Caffeine (36.1% market share).

What therapeutic categories does Base Pharmacy (india) cover?

Base Pharmacy (india) exports across 2 therapeutic categories. The largest are Respiratory & OTC (77.6%, 1 products), Combination Drugs (22.4%, 2 products).

Get Full Base Pharmacy (india) Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.